These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15304028)

  • 1. The effect of anticoagulant drugs on cancer.
    Falanga A
    J Thromb Haemost; 2004 Aug; 2(8):1263-5. PubMed ID: 15304028
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombosis and cancer: implications beyond Trousseau.
    Kakkar AK; Levine MN
    J Thromb Haemost; 2004 Aug; 2(8):1261-2. PubMed ID: 15304027
    [No Abstract]   [Full Text] [Related]  

  • 3. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
    Lee AY
    Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of anticoagulants on cancer: heparins.
    Pineo GF; Hull RD
    Cancer Treat Res; 2009; 148():259-75. PubMed ID: 19377929
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulants in cancer.
    Siegal DM; Garcia D
    J Thromb Haemost; 2012 Nov; 10(11):2230-41. PubMed ID: 22943367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anticoagulant agents: introduction.
    Schulman S
    J Intern Med; 2003 Oct; 254(4):308-12. PubMed ID: 12974869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of venous thrombosis.
    Lee AY
    Cancer Treat Res; 2009; 148():243-57. PubMed ID: 19377928
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-molecular-weight heparin and survival in patients with malignant disease.
    Kakkar AK
    Cancer Control; 2005 Sep; 12 Suppl 1():22-30. PubMed ID: 16179901
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Ageno W; Squizzato A
    Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: an update of the evidence.
    Hull RD; Townshend G
    Thromb Haemost; 2013 Jul; 110(1):14-22. PubMed ID: 23615656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of venous thromboembolism in cancer patients.
    Kakkar AK; Williamson RC
    Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins in thrombosis and cancer: emerging links.
    Mousa SA
    Cardiovasc Drug Rev; 2004; 22(2):121-34. PubMed ID: 15179449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients with venous thromboembolism and cancer be treated differently?
    Smorenburg SM; Hutten BA; Prins MH
    Haemostasis; 1999 Dec; 29 Suppl S1():91-7. PubMed ID: 10629414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin in the treatment of acute deep vein thrombosis and pulmonary embolism: A paradigm change in care.
    Merli GJ
    J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S21-7. PubMed ID: 10859581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty].
    Di Minno G; Tufano A
    Tumori; 2006; 92(6):suppl 1-15. PubMed ID: 17260505
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.